We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+0.09%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$15.4B
AUM Growth
-$4.25B
(-22%)
Cap. Flow
-$11.2B
Cap. Flow
% of AUM
-72.83%
Top 10 Holdings %
Top 10 Hldgs %
18.29%
Holding
643
New
38
Increased
264
Reduced
90
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$129M |
| 2 |
American International
AIG
|
+$82.2M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$74.9M |
| 5 |
Humana
HUM
|
+$67.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$92.5M |
| 2 |
Wells Fargo
WFC
|
+$55.4M |
| 3 |
AMT.PRB
American Tower Corporation
AMT.PRB
|
+$50.1M |
| 4 |
Apple
AAPL
|
+$48.6M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$36.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.23% |
| 2 | Technology | 9.26% |
| 3 | Healthcare | 8.87% |
| 4 | Communication Services | 6.39% |
| 5 | Consumer Discretionary | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CALL
iShares S&P 100 ETF
OEF
$19.8B
| $442M | 2.88% |
6,956,800
-10,062,700
| -59% | -$1.22B |
|
|
2
Apple
AAPL
$4.72T
| $384M | 2.5% |
9,164,056
-1,129,660
| -11% | -$48.6M |
|
3
Microsoft
MSFT
$2.83T
| $288M | 1.88% |
3,159,096
+28,732
| +0.9% | +$2.63M |
|
|
4
PUT
iShares S&P 100 ETF
OEF
$19.8B
| $278M | 1.81% |
4,989,500
+3,079,000
| +161% | +$373M |
|
5
Alphabet (Google) Class A
GOOGL
$3.88T
| $268M | 1.74% |
5,160,180
-190,180
| -4% | -$10.5M |
|
|
6
Meta Platforms (Facebook)
META
$1.54T
| $260M | 1.69% |
1,625,085
+417,186
| +35% | +$74.9M |
|
|
7
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$777B
| $257M | 1.67% |
975,000
-1,842,300
| -65% | -$503M |
|
8
Amazon
AMZN
$2.51T
| $235M | 1.53% |
3,253,900
-484,260
| -13% | -$34.6M |
|
9
JPMorgan Chase
JPM
$930B
| $200M | 1.3% |
1,822,658
-90,435
| -5% | -$10.2M |
|
10
Johnson & Johnson
JNJ
$624B
| $199M | 1.29% |
1,550,525
+114,913
| +8% | +$15.5M |
|
11
Bank of America
BAC
$430B
| $149M | 0.97% |
4,973,871
+400,168
| +9% | +$12.6M |
|
|
AGN
12
DELISTED
Allergan plc
AGN
| $128M | 0.83% |
760,302
+479,593
| +171% | +$80.4M |
|
|
13
State Street SPDR S&P 500 ETF Trust
SPY
$777B
| $125M | 0.81% |
473,837
+473,020
| +57,897% | +$129M |
|
14
Delta Air Lines
DAL
$53.9B
| $123M | 0.8% |
2,236,157
+308,993
| +16% | +$17M |
|
15
Visa
V
$669B
| $122M | 0.79% |
1,019,658
+11,767
| +1% | +$1.43M |
|
16
ExxonMobil
XOM
$650B
| $113M | 0.73% |
1,508,912
-117,678
| -7% | -$9.41M |
|
17
UnitedHealth
UNH
$385B
| $110M | 0.72% |
516,213
+163,116
| +46% | +$37.3M |
|
18
AbbVie
ABBV
$454B
| $107M | 0.69% |
1,127,011
+266,165
| +31% | +$29.2M |
|
19
Home Depot
HD
$324B
| $106M | 0.69% |
597,068
+53,727
| +10% | +$10.1M |
|
|
20
American International
AIG
$41.4B
| $95.5M | 0.62% |
1,755,265
+1,391,777
| +383% | +$82.2M |
|
21
Chevron
CVX
$387B
| $92.4M | 0.6% |
809,996
+8,542
| +1% | +$1.02M |
|
|
CCI.PRA
22
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $91.3M | 0.59% |
81,663
+14,420
| +21% | +$15.9M |
|
23
Walt Disney
DIS
$161B
| $91.2M | 0.59% |
908,274
+19,141
| +2% | +$2.03M |
|
24
Baxter International
BAX
$11.2B
| $86.2M | 0.56% |
1,325,483
-18,173
| -1% | -$1.23M |
|
25
CALL
Goldman Sachs
GS
$317B
| $85.7M | 0.56% |
+340,400
| New | +$88.6M |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, Calamos Advisors held 643 positions worth $15.4B, down 22% from $19.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Calamos Advisors withdrew a net $11.2B in Q1 2018, closing 44 positions and reducing 90 holdings. Its most notable exit was Allergan plc, an estimated $92.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 8.5% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Humana worth $67.1M.
- Calamos Advisors's largest Q1 2018 buy was Humana: 249,674 shares worth $67.1M.
- Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $129M increase.
- Calamos Advisors's biggest Q1 2018 reduction was Wells Fargo, cutting an estimated $55.4M.
- Calamos Advisors fully exited Allergan plc in Q1 2018, selling an estimated $92.5M.
- Calamos Advisors's ten largest holdings make up 18% of its $15.4B portfolio in Q1 2018.
- Calamos Advisors opened 38 new positions and closed 44 in Q1 2018.
- Calamos Advisors's portfolio value fell 22% quarter-over-quarter to $15.4B.
Based on Calamos Advisors's 13F filing for Q1 2018, filed 13 Apr 2018.